CJC‑1295 & Ipamorelin Therapy
US$ 28.64
dsip administration DSIP PEPTIDE 2MG/5MG VIAL –
Description
It is not suitable for human consumption, therapeutic applications, or diagnostic use
The peptide also has possible analgesic characteristics
In one study, BPC-157 was shown to reduce brain swelling and inflammation with topical application in rats with superior sagittal thrombosis
Vial Options: 5 mg, 10 mg, or 20 mg vials with optimized reconstitution for each size
